Published on :
With the Covid-19 pandemic, big pharma like Pfizer/BioNTech and Moderna hit the jackpot: pre-tax profits of $34 billion last year (2021), or $1,000 per second, according to the report. NGO People’s Vaccine Alliance. And they are not the only ones to benefit economically from the health crisis. Many companies benefit from new markets, which illustrate the general concern of the inhabitants of the planet for their health.
What are the industrial recipes for this success? What are the challenges for States negotiating contracts? What place should be given to innovation and how should it be financed? Where is Africa lagging behind in the development of these pharmaceutical industries?
Our guest :
– Nathalie Coutinet, health economist, lecturer at the University of Paris 13.
find us on: